<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23245">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01731613</url>
  </required_header>
  <id_info>
    <org_study_id>8648</org_study_id>
    <nct_id>NCT01731613</nct_id>
  </id_info>
  <brief_title>Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants</brief_title>
  <official_title>Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will compare how the individualized and fortified human milk feeding
      will help a premature infant grow.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Assessment of nutrient concentration of human milk</measure>
    <time_frame>participants will be followed until discharge, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical assessment of blood sample</measure>
    <time_frame>participants will be followed until discharge, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>participants will be followed until discharge, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body length and Head circumference</measure>
    <time_frame>participants will be followed until discharge, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Preterm Infant</condition>
  <arm_group>
    <arm_group_label>Standard Fortification</arm_group_label>
    <description>Standard Fortification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individualized Fortification</arm_group_label>
    <description>Individualized Fortification</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm Infants in China
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Less than 34 weeks gestational age at birth

          -  Birth weight within 800-1800 grams

          -  Exclusively or mostly breastfed (greater than 80% if the feeding volume)

          -  Tolerated enteral feedings of 60 ml/kg/d

          -  Remain in the Neonatal Intensive Care Unit at least 14 days prior to hospital
             discharge,remain in the Neonatal Intensive Care Unit at least 10 days after
             enrollment

          -  Signed Informed Consent

        Exclusion Criteria:

          -  Small for gestational age

          -  Infants currently receiving ventilation therapy

          -  Major congenital malformations

          -  Suspected or documented systemic or congenital infections

          -  Evidence of cardiac, respiratory, endocrinologic, hematologic, gastrointestinal, or
             other systemic diseases that may impact growth

          -  Severe intraventricular hemorrhage (greater than grade II) or periventricular
             leukomalacia

          -  Suspected or documented maternal substance abuse

          -  Infants currently receiving glucocorticoids or infants who have received
             glucocorticoids within the past 28 days
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>40 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danhua Wang, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danhua Wang</last_name>
      <phone>8610+15910806977</phone>
    </contact>
    <investigator>
      <last_name>Danhua Wang, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 16, 2012</lastchanged_date>
  <firstreceived_date>November 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Danhua Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
